logo
episode-header-image
Feb 2024
35m 23s

Cancer's power harnessed — lymphoma muta...

SPRINGER NATURE LIMITED
About this episode
tail spinning
Up next
Sep 4
Briefing Chat: How 1,000 pairs of buried underpants helped measure soil health
In this episode:00:21 Our picks of this year’s Ig Nobel prizesNature: Buried underpants and a new definition of kissing win 2026 Ig Nobel prizes07:47 Massive xenon experiment detects tantalizing hint of dark matterNature: Is this the first glimpse of dark matter? Data point excit ... Show More
12m 24s
Sep 2
Audio long read: Could mending damaged DNA prolong life?
Scientists are amassing evidence that unrepaired or poorly repaired DNA damage underlies many of the hallmarks of ageing. This has led to research into whether boosting DNA repair can keep people healthy for longer.This is an audio version of our Feature: Could mending damaged DN ... Show More
18m 16s
Aug 28
Briefing Chat: How Dolly Parton left her mark on science
In this episode:00:18 Researchers celebrate Dolly Parton's contributions to scienceNature: Dolly Parton dies aged 80 — researchers celebrate her contributions to science08:40 Phase III trial of melanoma vaccine shows promiseNature: Moderna cancer vaccine stops melanoma returning: ... Show More
14m 5s
Recommended Episodes
Jun 2023
Unleashing CRISPR on Cancer
In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ... Show More
52m 50s
Jun 2025
Reprogramming Immunity: Unlocking CAR-NK Cells with Dr. Hind Rafei
<p>In this episode, Dr. Hind Rafei dives into the cutting-edge world of CAR-NK cell therapy and its potential to revolutionize cancer treatment. Unlike their T-cell counterparts, CAR-NK cells promise enhanced safety and innate tumor-killing ability. But what if their power could ... Show More
26m 51s
Jan 2018
Immune 4: Putting the immunotherapy CAR T before the cancer
<p>The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.</p> <p>Hosts: <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello" target="_blank" rel="noopener">Vincent Racaniello</a ... Show More
1h 23m
Apr 2024
CAR T-Cells and Safety Signals
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400701. 
25m 25s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
<p>CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott ... Show More
18m 22s
Mar 2013
Cancer Immunlogy
Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. Immunotherapy stimulates the body's immune system, and can be a powerful treatment for cancer. The most efficient prophylactic cancer vaccine today is the vaccine a ... Show More
7m 33s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
May 2024
Triomics raises $15M Series A to automate cancer clinical trials matching
For cancer patients, medicines administered in clinical trials can help save or extend lives. Learn more about your ad choices. Visit podcastchoices.com/adchoices 
4m 8s
May 2023
A cancer vaccine?
Dr. Vinod Balachandran explains how he and his colleagues successfully treated pancreatic cancer with bespoke mRNA vaccines. Science journalist Charles Graeber says this could be cancer’s “penicillin moment.” This episode was produced by Avishay Artsy, edited by Matt Collette, fa ... Show More
26m 6s